Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Molecular Biology & Medicine|August 1, 1989
Activity of a metallothionein-transthyretin fusion gene in transgenic mice. Possible effect of plasmid sequences on tissue-specific expressionH Sasaki, M Nakazato, M J Saraiva, et al.The Journal of Clinical Investigation|July 1, 1984
Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin)M J Saraiva, S Birken, P P Costa, et al.Neuromuscular Disorders : NMD|May 1, 1995
TTR exon scanning in peripheral neuropathiesM de F Torres, M do R Almeida, M J SaraivaArquivos Brasileiros De Cardiologia|October 22, 2003
Behavior of inflammatory markers of myocardial injury in cardiac surgery: laboratory correlation with the clinical picture of postpericardiotomy syndromeIlmar Köhler, Paulo J Saraiva, Orlando B Wender, et al.Neuroscience Letters|February 9, 1996
Transthyretin gene in Alzheimer's disease patientsJ A Palha, P Moreira, T Wisniewski, et al.The American Journal of Pathology|December 6, 2001
Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregatesM M Sousa, I Cardoso, R Fernandes, et al.Journal of Molecular Medicine (Berlin, Germany)|July 4, 2001
Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathyJ A Palha, P Moreira, A Olofsson, et al.Acta Crystallographica. Section D, Biological Crystallography|November 29, 2011
Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrilsArtur F Castro-Rodrigues, Luís Gales, Maria J Saraiva, et al.Journal of Molecular Biology|November 25, 2000
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrilsC Redondo, A M Damas, A Olofsson, et al.Idcases|September 2, 2016
Cytomegalic hepatitis in a patient receiving omalizumabR Gonçalves, C Valente, E Ferreira, et al.Pageof 18